Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...
A new study from Loyola University demonstrates that GLP-1 receptor agonists like Ozempic can help treat substance use ...
The Korea Ginseng Corporation received approval from the Food & Drug Administration o market ginseng as an aid in blood ...
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
Ozempic could cut binge drinking and opioid abuse, major research suggests. A US study of more than 800,000 people with a ...
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts.
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...